Longeveron Inc (LGVN)
1.68
0.00 (0.00%)
USD |
NASDAQ |
May 07, 12:03
Longeveron Free Cash Flow (Quarterly): -4.256M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.256M |
September 30, 2023 | -4.671M |
June 30, 2023 | -4.806M |
March 31, 2023 | -5.963M |
December 31, 2022 | -2.466M |
September 30, 2022 | -4.717M |
June 30, 2022 | -3.372M |
March 31, 2022 | -4.27M |
Date | Value |
---|---|
December 31, 2021 | -2.434M |
September 30, 2021 | -2.404M |
June 30, 2021 | -3.076M |
March 31, 2021 | -3.032M |
December 31, 2020 | -0.545M |
September 30, 2020 | -0.273M |
June 30, 2020 | -1.269M |
March 31, 2020 | -0.538M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.963M
Minimum
Mar 2023
-0.273M
Maximum
Sep 2020
-3.006M
Average
-3.054M
Median
Free Cash Flow (Quarterly) Benchmarks
Palatin Technologies Inc | -10.51M |
BioSig Technologies Inc | -2.946M |
Adial Pharmaceuticals Inc | -1.223M |
Outset Medical Inc | -25.50M |
MSP Recovery Inc | -8.691M |